S4E1: New RNA platform can predict pregnancy complications

Podcast

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Ivie Odiase, MD
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Laxmi Gannu, MD, notes PPD screening gaps and adverse outcomes | Image Credit: linkedin.com.
Farah Amro, MD
Related Content
New guidelines stress preconception care for women with diabetes | Image Credit: © zakalinka - © zakalinka - stock.adobe.com.

New guidelines stress preconception care for women with diabetes

Celeste Krewson, Assistant Editor
July 14th 2025
Article

Joint recommendations highlight the importance of screening, medication management, and contraception counseling to improve pregnancy outcomes in women with diabetes.

Read More

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Lindsey Carr, Editor
December 22nd 2022
Podcast

This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Listen

Contemporary OB/GYN week in review: vaping, influenza vaccination, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: vaping, influenza vaccination, and more

Celeste Krewson, Assistant Editor
July 11th 2025
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

Lindsey Carr, Editor
December 21st 2022
Podcast

This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Listen

Pro-inflammatory diet in pregnancy tied to diabetes in offspring | Image Credit: © vaaseenaa - stock.adobe.com.

Pro-inflammatory diet in pregnancy tied to diabetes in offspring

Morgan Ebert, Managing Editor
July 9th 2025
Article

A pro-inflammatory maternal diet during pregnancy was linked to a 16% higher risk of type 1 diabetes in offspring, Danish cohort study finds.

Read More

Pregnancy complications linked to long-term stroke risk | Image Credit: © Chinnapong - © Chinnapong- stock.adobe.com.

Pregnancy complications linked to long-term stroke risk

Celeste Krewson, Assistant Editor
July 8th 2025
Article

A major study of over 2 million women reveals that common pregnancy complications significantly increase the risk of stroke decades later.

Read More

© 2025 MJH Life Sciences

All rights reserved.